Clinical Program Manager (Biotech)

Location: United States, California, Foster City

Salary: $182,070–$235,620 per year for the Bay Area; $165,495–$214,170 per year in other US locations. Additional eligibility may include an annual bonus, long-term stock incentives, paid time off, and benefits.

Company

Develops cancer immunotherapies, including CAR T-cell and T-cell receptor engineered cell therapies, to provide durable responses and reduce the burden of chronic care.

What you will do

• Lead the successful execution of one or more Phase I–IV clinical studies and programs within defined budgets and timelines.
• Manage direct and potentially indirect reports, including hiring, coaching, development, performance management, and retention.
• Lead cross-functional Study Management Teams and influence stakeholders across Clinical Operations and related functions.
• Manage study resources, project timelines, budgets, risks, issues, and mitigation plans.
• Oversee CRO and vendor selection and management, including requests for proposals.
• Develop and maintain study protocols, regulatory documentation, SOPs, training, and process improvements in line with applicable regulations.

Requirements

• Bachelor’s degree with eight years of experience, master’s degree with six years of experience, or PhD/PharmD.
• Cross-functional study management or related leadership experience in life sciences, including experience managing study or project teams.
• Experience starting, managing, and closing clinical studies and authoring clinical study, regulatory, and SOP documentation.
• Knowledge of FDA, EMA, ICH, GCP, and other applicable national regulations.
• Ability to lead and influence programs, manage change, coach others, and work effectively in a highly matrixed environment.
• Ability to travel when needed.

Culture & Benefits

• People leadership focused on inclusion, talent development, team empowerment, and career growth.
• Medical, dental, vision, and life insurance plans for eligible employees.
• Paid time off and potential discretionary annual bonus and stock-based long-term incentives.
• Work supporting innovative cancer therapies and global clinical development programs.